Total protein: what the albumin-to-globulin split reveals

What total protein actually represents in plasma

Total protein measures the combined concentration of albumin and globulins in your plasma, reported in grams per deciliter (g/dL). Albumin is the major carrier protein synthesized by the liver — it maintains fluid balance and transports hormones, drugs, and nutrients. Globulins include antibodies and other immune proteins that defend against infection. Together, these two fractions account for nearly all circulating blood protein, and their combined level reflects the state of liver synthesis, nutritional supply, and immune activity.

How albumin and globulins together tell the story

Albumin functions as the body's primary transport protein — ferrying hormones and nutrients through the bloodstream — while globulins serve the immune system, scanning for and responding to threats. When both fractions are in balance, total protein stays steady. When one shifts, the combined number reflects that strain.

Total protein does not measure individual protein fractions — identifying those requires protein electrophoresis. This distinction matters clinically: in chronic inflammation, albumin falls (it is a negative acute-phase reactant) while globulins rise (positive acute-phase reactants), so total protein can remain within the normal range even when significant nutritional or inflammatory pathology is present. The albumin-to-globulin (A/G) ratio can reveal this masking effect when total protein alone misses it.

Beyond its role as a nutrition marker, total protein reflects how well the body manages both transport and defense. Persistent low levels are associated with accelerated frailty, impaired wound healing, and immune vulnerability. Chronically elevated globulins can signal smoldering inflammation that erodes long-term resilience. In this sense, a stable total protein indicates that metabolic, hepatic, and immune systems are functioning in concert.

Reading low, normal, and high total protein

Normal range

Reference ranges vary slightly between laboratories, but the broadly accepted normal range for total protein in adults is 6.0–8.3 g/dL, with most healthy individuals clustering near 7.0 g/dL. Within that range, the A/G ratio — often reported alongside total protein — provides interpretive refinement: a low ratio can suggest chronic inflammation or immune activation, while a high ratio may reflect low antibody production or a concentrating effect from dehydration.

When levels run high

Elevated total protein most commonly reflects dehydration, where reduced plasma water concentrates all proteins. It can also indicate chronic inflammation or immune overactivity — conditions such as autoimmune disease or chronic infection drive globulin production upward. At the higher end, markedly elevated total protein may point to abnormal antibody production from a plasma cell disorder such as multiple myeloma; serum protein electrophoresis is the appropriate follow-up test to characterize that possibility.

When levels run low

Total protein below 6.0 g/dL generally reflects a deficit in production, supply, or retention. Inadequate dietary protein intake limits the substrate available for albumin synthesis. Liver dysfunction reduces the liver's capacity to produce albumin directly. Nephrotic syndrome causes excessive protein loss through the kidneys, depleting circulating levels despite normal intake and liver function. Overhydration or severe acute illness can also dilute or suppress protein levels. When low total protein persists, albumin, liver enzymes, and kidney function markers help identify which mechanism is responsible.

Why total protein moves between draws

Dietary protein intake is a primary driver of albumin levels. Adequate dietary protein supports albumin synthesis; deficiency is a direct cause of low total protein. The effect is gradual, reflecting albumin's approximately three-week half-life.

Hydration state has an immediate concentrating or diluting effect on all plasma proteins. Dehydration raises apparent total protein; overhydration lowers it — without any change in actual protein synthesis or loss.

Liver function governs albumin production. Any condition that impairs hepatic synthesis — including liver disease, cirrhosis, or significant hepatocellular injury — will reduce the albumin fraction and pull total protein down.

Chronic inflammation shifts the balance between fractions. As a negative acute-phase reactant, albumin is suppressed during inflammatory states; globulins, as positive acute-phase reactants, rise. Total protein may appear stable while the underlying composition has shifted substantially.

Kidney function affects protein retention. Conditions causing proteinuria, particularly nephrotic syndrome, result in ongoing protein loss that lowers total protein regardless of intake or synthesis.

Certain medications — including corticosteroids and immunosuppressants — can alter protein metabolism and affect results. Results are best interpreted alongside trends and companion markers rather than as isolated values.

Markers that read total protein in context

• Albumin — albumin is the largest single component of total protein; when total protein falls, albumin status confirms whether the deficit lies in the transport and synthesis fraction or the immune fraction.
• Albumin/globulin ratio — the A/G ratio separates what total protein cannot: a normal total protein with a low A/G ratio signals high globulins masking low albumin, pointing to immune activation, liver dysfunction, or nutritional deficit.
• Alanine aminotransferase (ALT) — ALT signals liver cell injury; low total protein combined with elevated ALT supports hepatic synthesis failure as the cause of the protein deficit.
• hs-CRP — hs-CRP confirms whether active inflammation is driving globulin elevation and albumin suppression, explaining a deceptively normal total protein result.
• Globulin — when elevated total protein appears driven by the globulin fraction, a globulin breakdown or serum protein electrophoresis is warranted to rule out a monoclonal protein.

A realistic retest window for total protein

Total protein is a slow-moving marker. Albumin, its dominant fraction, has a half-life of approximately three weeks, meaning meaningful changes in synthesis or loss take weeks to months to register. Retesting within days or a few weeks after a single abnormal result is unlikely to reflect a true biological shift — it more often captures hydration variability or short-term illness.

For most adults, total protein is appropriately monitored every 6–12 months as part of a routine comprehensive metabolic panel (CMP). More frequent monitoring is reasonable when tracking known liver disease, recovering from significant nutritional deficit, or managing a condition that directly affects protein metabolism — such as nephrotic syndrome or inflammatory bowel disease. When retesting, consistent conditions matter: the same laboratory, the same fasting state, and comparable hydration help ensure that changes between draws reflect biology rather than pre-analytical variation.

When total protein results warrant a clinician's review

Total protein is part of nearly every comprehensive metabolic panel because it reflects both the body's protein resources and its capacity to deploy them. A result outside the 6.0–8.3 g/dL range — or a trend moving toward either boundary across sequential draws — is a signal worth discussing with a clinician, particularly when accompanied by changes in albumin, liver enzymes, kidney markers, or inflammatory indicators.

Persistently low total protein alongside low albumin and elevated ALT points toward hepatic synthesis failure. Low total protein with significant proteinuria points toward renal protein loss. Elevated total protein with a low A/G ratio and high hs-CRP points toward an inflammatory or immune-driven globulin excess — a pattern that may warrant serum protein electrophoresis to exclude a plasma cell disorder. In each case, total protein is the starting signal; the companion markers define the pathway.

Superpower tracks total protein alongside albumin, globulin, liver enzymes, and inflammatory markers, mapping how these proteins shift with changes in diet, hydration, and systemic health. Trends invisible in a single draw become clear across time. Learn more about the approach at our manifesto, or explore advanced biomarker testing with over 100 biomarkers.